FDA Withdraws Proposed Talc Cosmetics Testing Rule - law360.com
FDA Withdraws Proposed Talc Cosmetics Testing Rule - law360.com — cosmetics, FDA, talc update affecting Cosmetics & Personal-Care (MoCRA).
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on September 12, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetics & Personal-Care (MoCRA) (indie beauty brands, contract manufacturers, private-label makers, importers/distributors) should confirm how it applies to their specific situation before acting. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Cosmetics & Personal-Care (MoCRA) move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
FDA Withdraws Proposed Talc Cosmetics Testing Rule - law360.com
Who it affects
Cosmetics & Personal-Care (MoCRA) (indie beauty brands, contract manufacturers, private-label makers, importers/distributors)
What you must do
Read the update and assess whether your current setup needs to change.
Deadline
No fixed deadline was published, but changes like this are often enforced quickly — act promptly.
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Customer/Partner Customer Service Satisfaction Surveys
- Time’s Up! Cosmetic Facilities Must Comply With FDA’s New Registration Requirements by July 1 - wiley.law
- Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Tracking
- Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate
- New York will not let 3M and DuPont forget PFAS scandal - iclg.com